Challenges for environmental epidemiology research: Are biomarker concentrations altered by kidney function or urine concentration adjustment?

Journal of Exposure Science and Environmental Epidemiology

Volumn 26, Issue 1, 2016, Pages 1-8

  Weaver, Virginia M ^a,b,c   Kotchmar, Dennis J ^d   Fadrowski, Jeffrey J ^b,c   Silbergeld, Ellen K ^a  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

biomarkers; biomonitoring; creatinine; glomerular filtration rate (GFR); kidney function; reverse causality

Indexed keywords

BIOLOGICAL MARKER; CADMIUM; CREATININE;

ADOLESCENT; ADULT; AGED; ANALYSIS; CHILD; ENVIRONMENTAL MONITORING; EPIDEMIOLOGY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFANT; KIDNEY CONCENTRATING CAPACITY; MALE; METABOLISM; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PRESCHOOL CHILD; PROCEDURES; URINE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CADMIUM; CHILD; CHILD, PRESCHOOL; CREATININE; ENVIRONMENTAL MONITORING; EPIDEMIOLOGIC STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFANT; KIDNEY CONCENTRATING ABILITY; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; YOUNG ADULT;

EID: 84952638957     PISSN: 15590631     EISSN: 1559064X     Source Type: Journal    
DOI: 10.1038/jes.2015.8     Document Type: Article

References (42)

1. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005; 113: 192-200.
2. Comper WD, Russo LM. The glomerular filter: an imperfect barrier is required for perfect renal function. Curr Opin Nephrol Hypertens 2009; 18: 336-342.
3. Bernard A, Thielemans N, Roels H, Lauwerys R. Association between NAG-B and cadmium in urine with no evidence of a threshold. Occup Environ Med 1995; 52: 177-180.
4. D'Amico G, Bazzi C. Urinary protein and enzyme excretion as markers of tubular damage. Curr Opin Nephrol Hypertens 2003; 12: 639-643.
5. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification Guideline 1: definition and stages of chronic kidney disease. Am J Kidney Dis 2002; 39: S1.
6. Evans M, Elinder CG. Chronic renal failure from lead: myth or evidence-based fact Kidney Int 2011; 79: 272-279.
7. Marsden PA. Increased body lead burden-cause or consequence of chronic renal insufficiency N Engl J Med 2003; 348: 345-347.
8. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
9. National Kidney Foundation. Glomerular Filtration Rate (GFR) FAQ's. page 4. http://www.kidney.org/professionals/kdoqi/gfr.cfm Accessed August 4, 2013.
10. Nawrot T, Plusquin M, Hogervorst J, Roels HA, Celis H, Thijs L et al. Environmental exposure to cadmium and risk of cancer: a prospective population-based study. Lancet Oncol 2006; 7: 119-126.
11. Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC et al. Lowlevel environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 2005; 113: 894-899.
12. Akerstrom M, Barregard L, Lundh T, Sallsten G. The relationship between cadmium in kidney and cadmium in urine and blood in an environmentally exposed population. Toxicol Appl Pharmacol 2013; 268: 286-293.
13. Nenov VD, Taal MW, Sakharova OV, Brenner BM. Multi-hit nature of chronic renal disease. Curr Opin Nephrol Hypertens 2000; 9: 85-97.
14. Khalil-Manesh F, Gonick HC, Cohen AH, Alinovi R, Bergamaschi E, Mutti A et al. Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int 1992; 41: 1192-1203.
15. de Burbure C, Buchet JP, Leroyer A, Nisse C, Haguenoer JM, Mutti A et al. Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ Health Perspect 2006; 114: 584-590.
16. Weaver VM, Lee BK, Ahn KD, Lee GS, Todd AC, Stewart WF et al. Associations of lead biomarkers with renal function in Korean lead workers. Occup Environ Med 2003; 60: 551-562.
17. Chaumont A, Nickmilder M, Dumont X, Lundh T, Skerfving S, Bernard A. Associations between proteins and heavy metals in urine at low environmental exposures: Evidence of reverse causality. Toxicol Lett 2012; 210: 345-352.
18. Van Kerkhove E, Pennemans V, Swennen Q. Cadmium and transport of ions and substances across cell membranes and epithelia. Biometals 2010; 23: 823-855.
19. Weaver VM, Kim NS, Lee BK, Parsons PJ, Spector J, Fadrowski J et al. Differences in urine cadmium associations with kidney outcomes based on serum creatinine and cystatin C. Environ Res 2011; 111: 1236-1242.
20. Kim R, Rotnitsky A, Sparrow D, Weiss S, Wager C, Hu H. A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study. JAMA 1996; 275: 1177-1181.
21. Watkins DJ, Josson J, Elston B, Bartell SM, Shin HM, Vieira VM et al. Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant. Environ Health Perspect 2013; 121: 625-630.
22. Sommar JN, Svensson MK, Bjor BM, Elmstahl SI, Hallmans G, Lundh T et al. Endstage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden. Environ Health 2013; 12: 9.
23. Boeniger MF, Lowry LK, Rosenberg J. Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: A review. Am Ind Hyg Assoc J 1993; 54: 615-627.
24. Suwazono Y, Akesson A, Alfven T, Jarup L, Vahter M. Creatinine versus specific gravity-adjusted urinary cadmium concentrations. Biomarkers 2005; 10: 117-126.
25. Aylward LL, Hays SM, Smolders R, Koch HM, Cocker J, Jones K et al. Sources of variability in biomarker concentrations. J Toxicol Environ Health B Crit Rev 2014; 17: 45-61.
26. Abdelmalek JA, Gansevoort RT, Lambers Heerspink HJ, Ix JH, Rifkin DE. Estimated albumin excretion rate versus urine albumin-creatinine ratio for the assessment of albuminuria: a diagnostic test study from the Prevention of Renal and Vascular Endstage Disease (PREVEND) Study. Am J Kidney Dis 2014; 63: 415-421.
27. Yassine H, Kimzey MJ, Galligan MA, Gandolfi AJ, Stump CS, Lau SS. Adjusting for urinary creatinine overestimates arsenic concentrations in diabetics. Cardiorenal Med 2012; 2: 26-32.
28. Wald R. Urinalysis in the diagnosis of kidney disease. In: Basow D (ed). UpToDate. UpToDate: Waltham, MA, 2013.
29. Rose B, Post T. Chapter 13B: Meaning of urine osmolality and pH. In: Basow D (ed). UpToDate. UpToDate: Waltham, MA, 2013.
30. Waikar SS, Sabbisetti VS, Bonventre JV. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int 2010; 78: 486-494.
31. Akerstrom M, Lundh T, Barregard L, Sallsten G. Sampling of urinary cadmium: differences between 24-h urine and overnight spot urine sampling, and impact of adjustment for dilution. Int Arch Occup Environ Health 2012; 85: 189-196.
32. Akerstrom M, Barregard L, Lundh T, Sallsten G. Variability of urinary cadmium excretion in spot urine samples, first morning voids, and 24 h urine in a healthy non-smoking population: implications for study design. J Expo Sci Environ Epidemiol 2014; 24: 171-179.
33. Moriguchi J, Ezaki T, Tsukahara T, Furuki K, Fukui Y, Okamoto S et al. Comparative evaluation of four urinary tubular dysfunction markers, with special references to the effects of aging and correction for creatinine concentration. Toxicol Lett 2003; 143: 279-290.
34. Ikeda M, Ezaki T, Tsukahara T, Moriguchi J, Furuki K, Fukui Y et al. Bias induced by the use of creatinine-corrected values in evaluation of beta2-microgloblin levels. Toxicol Lett 2003; 145: 197-207.
35. Shelley R, Kim NS, Parsons PJ, Lee BK, Agnew J, Jaar BG et al. Uranium associations with kidney outcomes vary by urine concentration adjustment method. J Expo Sci Environ Epidemiol 2014; 24: 58-64.
36. Akesson A, Lundh T, Vahter M, Bjellerup P, Lidfeldt J, Nerbrand C et al. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect 2005; 113: 1627-1631.
37. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
38. Weaver VM, Vargas GG, Silbergeld EK, Rothenberg SJ, Fadrowski JJ, Rubio-Andrade M et al. Impact of urine concentration adjustment method on associations between urine metals and estimated glomerular filtration rates (eGFR) in adolescents. Environ Res 2014; 132C: 226-232.
39. Christensen K, Sobus J, Phillips M, Blessinger T, Lorber M, Tan YM. Changes in epidemiologic associations with different exposure metrics: A case study of phthalate exposure associations with body mass index and waist circumference. Environ Int 2014; 73C: 66-76.
40. Ferraro PM, Costanzi S, Naticchia A, Sturniolo A, Gambaro G. Low level exposure to cadmium increases the risk of chronic kidney disease: analysis of the NHANES 1999-2006. BMC Public Health 2010; 10: 304.
41. You L, Zhu X, Shrubsole MJ, Fan H, Chen J, Dong J et al. Renal function, bisphenol A, and alkylphenols: results from the National Health and Nutrition Examination Survey (NHANES 2003-2006). Environ Health Perspect 2011; 119: 527-533.
42. Shelley R, Kim NS, Parsons P, Lee BK, Jaar B, Fadrowski J et al. Associations of multiple metals with kidney outcomes in lead workers. Occup Environ Med 2012; 69: 727-735.